Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intellia Thera CS (NQ: NTLA )

14.79 +0.49 (+3.43%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,826,584
Open 14.89
Bid (Size) 14.72 (1)
Ask (Size) 14.84 (2)
Prev. Close 14.30
Today's Range 14.41 - 15.24
52wk Range 12.82 - 34.87
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?
Via The Motley Fool
From GLD To TSLA: Unlocking Today’s Best Trading Opportunities
The week kicks off amidst significant market movements shaped by geopolitical and policy developments. 
Via Talk Markets
Topics Stocks / Equities

Performance

YTD
-52.01%
-52.01%
1 Month
-7.27%
-7.27%
3 Month
-37.28%
-37.28%
6 Month
-34.90%
-34.90%
1 Year
-51.75%
-51.75%

More News

Read More
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
9 Analysts Have This To Say About Intellia Therapeutics
Via Benzinga
3 Fast-Growing Stocks Analysts See Doubling in Price
Via MarketBeat
A Glimpse of Intellia Therapeutics's Earnings Potential
Via Benzinga
Looking Into Intellia Therapeutics's Recent Short Interest
Via Benzinga
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
Via The Motley Fool
This Beaten-Down Stock Could Soar by 354%, According to Wall Street
Via The Motley Fool
12 High-Growth Stocks That Could Deliver Parabolic Returns
Via The Motley Fool
7 Analysts Have This To Say About Intellia Therapeutics
Via Benzinga
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
A Closer Look at Intellia Therapeutics's Options Market Dynamics
Via Benzinga
3 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Expert Outlook: Intellia Therapeutics Through The Eyes Of 7 Analysts
Via Benzinga
Why Intellia Therapeutics Stock Plummeted by 20% Today
Via The Motley Fool
Why Is Gene Therapy-Focused Intellia Therapeutics Stock Trading Lower On Thursday?
Via Benzinga
This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
Via The Motley Fool
2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street
Via The Motley Fool
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
Via The Motley Fool
Expert Ratings For Intellia Therapeutics
Via Benzinga
3 Gene Editing Stocks with Potential to Transform Medicine
Via InvestorPlace
NTLA Stock Earnings: Intellia Therapeutics Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.